FindTrial
Sign In

Canceled by the investigator. Effect of long-term oral ACEI or ARB medications on outcome and sympathetic nerves in hypertensive patients infected with Omicron: a retrospective study

Effect of long-term oral ACEI or ARB medications on outcome and sympathetic nerves in hypertensive patients infected with Omicron

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067322
Enrollment
Unknown
Registered
2023-01-04
Start date
2023-01-05
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

ACEIs/ARB group vs. non-ACEIs/ARB group:None

Sponsors

Shanghai Fourth People's Hospital, Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. COVID-19 patients (asymptomatic, mild, common, severe, and critical) diagnosed by the diagnostic criteria and clinical staging methods of the New Coronavirus Pneumonia Diagnosis and Treatment Program (Trial Ninth Edition); 2. Combined with essential hypertension, taking antihypertensive drugs regularly for >= 1 month.

Exclusion criteria

Exclusion criteria: 1. The survival time after hospitalization is <= 48 hours; 2. The positive time or negative time of viral nucleic acid cannot be clearly determined.

Design outcomes

Primary

MeasureTime frame
mortality;Length of nucleic acid turning negative;—

Secondary

MeasureTime frame
blood pressure;heart rate;pulse;Hospital admission;—

Countries

China

Contacts

Public ContactChen Hui

Shanghai Fourth People's Hospital, Tongji University

chenhui_md@163.com+86 130 0313 1393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026